Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma × Brachytherapy × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 12 Neoplasms 4 Breast Neoplasms 3 Vaginal Neoplasms 2 Uterine Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Vulvar Neoplasms 1 Stage IA Uterine Sarcoma 1 Radiation Injuries 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Adenocarcinoma 1 Desmoplastic Small Round Cell Tumor 1 Cholangiocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 11 Cisplatin 11 Capecitabine 11 Oxaliplatin 9 Fluorouracil 9 130-nm albumin-bound paclitaxel 8 pembrolizumab 7 Paclitaxel 7 Ramucirumab 6 Leucovorin 6 Carboplatin 6 Bevacizumab 6 Pemetrexed 4 Nivolumab 4 Irinotecan 4 Everolimus 4 Erlotinib Hydrochloride 4 Docetaxel 4 Cyclophosphamide 4 Albumin-Bound Paclitaxel 4 trastuzumab deruxtecan 3 Radiotherapy 3 Afatinib 3 zolbetuximab 2 pralsetinib 2 cabozantinib 2 Trastuzumab 2 Ipilimumab 2 vosaroxin 1 vandetanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡